Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services by leveraging inhouse capacity combined with the expertise of the nation’s leading academic vector production and research laboratories.
Solutions to Propel
Your Therapies Forward
We are focused on driving your breakthrough gene and cell therapies from bench to clinic. As your partner, our focus is providing unyielding support to overcome all manufacturing barriers and accelerate your clinical drug development programs. Our services have been purposefully designed to accommodate clinical drug development activities—from process development to manufacturing and product release. Our 25,000 sq. ft. facility is located in the Midwest with logistical accessibility and augmented with the best and brightest minds to support your distinct needs. Let’s start a conversation.
Newly added manufacturing facility: 25,000 sq. ft. and cGMP-compliant cleanroom suites at ISO 7 and ISO 8
Suspension viral vector production: Up to 200L
Adherent viral vector production: Up to 70L
Process development to ramp from pre-clinical through clinical trials
Tailored R&D grade and at scale non-GMP productions
GMP vector production capabilities in both adherent and suspension cell lines
Scalable manufacturing capacity with suspension production and clonal selection for producer cell lines
Expertise to envision later phase production requirements
Field experience and connections
Production accuracy and reliability
Proven success with wide range of organization sizes
For more information on our services, contact us at firstname.lastname@example.org or submit this form.
9900 Westpoint Dr, Suite 128
Indianapolis, IN 46256
Follow Us On Social